{
    "2021-09-13": [
        [
            {
                "time": "",
                "original_text": "医药生物行业中报透视CXO：板块增长强劲 边际变化持续向好",
                "features": {
                    "keywords": [
                        "医药生物",
                        "CXO",
                        "板块增长",
                        "边际变化"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药",
                        "生物科技"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "万泰生物：公司2价HPV疫苗处于满负荷生产状态，主要供应国内，暂无出口",
                "features": {
                    "keywords": [
                        "万泰生物",
                        "2价HPV疫苗",
                        "满负荷生产",
                        "国内供应"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药",
                        "疫苗"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "万泰生物：9价HPV疫苗是公司重要的在研疫苗项目之一",
                "features": {
                    "keywords": [
                        "万泰生物",
                        "9价HPV疫苗",
                        "在研项目"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药",
                        "疫苗"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "",
                "original_text": "万泰生物：创新疫苗是公司两大核心主营业务之一，公司暂无疫苗分拆上市的计划",
                "features": {
                    "keywords": [
                        "万泰生物",
                        "创新疫苗",
                        "主营业务",
                        "分拆上市"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药",
                        "疫苗"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "",
                "original_text": "万泰生物：今年上半年新冠试剂占试剂板块收入的比重不到20%",
                "features": {
                    "keywords": [
                        "万泰生物",
                        "新冠试剂",
                        "试剂板块",
                        "收入占比"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药",
                        "诊断试剂"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "万泰生物：第三代（20价）HPV疫苗目前尚处在工艺验证的阶段",
                "features": {
                    "keywords": [
                        "万泰生物",
                        "20价HPV疫苗",
                        "工艺验证"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药",
                        "疫苗"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "",
                "original_text": "万泰生物：公司新冠抗原自检试剂相继获得德国BfArM认证和法国ANSM认证",
                "features": {
                    "keywords": [
                        "万泰生物",
                        "新冠抗原自检试剂",
                        "德国BfArM认证",
                        "法国ANSM认证"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药",
                        "诊断试剂"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "万泰生物：当前二价HPV疫苗随访数据无法得出单剂疫苗保护效果及免疫持久性的确切结论",
                "features": {
                    "keywords": [
                        "万泰生物",
                        "二价HPV疫苗",
                        "随访数据",
                        "保护效果"
                    ],
                    "sentiment_score": 0.4,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药",
                        "疫苗"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "万泰生物：公司核酸检测试剂有供应广东地区",
                "features": {
                    "keywords": [
                        "万泰生物",
                        "核酸检测试剂",
                        "广东地区"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药",
                        "诊断试剂"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "万泰生物：公司二价HPV疫苗没有使用山东药玻的玻璃瓶",
                "features": {
                    "keywords": [
                        "万泰生物",
                        "二价HPV疫苗",
                        "山东药玻",
                        "玻璃瓶"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药",
                        "疫苗"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "",
                "original_text": "万泰生物：公司并没有直接或间接投资洛阳中科生物",
                "features": {
                    "keywords": [
                        "万泰生物",
                        "洛阳中科生物",
                        "投资"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药",
                        "生物科技"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "",
                "original_text": "万泰生物：公司现在生产销售的疫苗是2价HPV疫苗和戊肝疫苗",
                "features": {
                    "keywords": [
                        "万泰生物",
                        "2价HPV疫苗",
                        "戊肝疫苗",
                        "生产销售"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药",
                        "疫苗"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}